Retrieve available abstracts of 17 articles: HTML format
Single Articles
July 2025
NAYYER MA, Rasool H, Murtaza H, Safdar MR, et al Tegoprazan vs. proton pump inhibitors for erosive esophagitis: a superior
alternative or just another option? A systematic review and meta-analysis of
randomized controlled trials.
Eur J Gastroenterol Hepatol. 2025 Jul 14. doi: 10.1097/MEG.0000000000003030. PubMedAbstract available
June 2025
CALABRESE F, Pasta A, Bodini G, Furnari M, et al Autoimmune chronic atrophic gastritis: association between chronic proton pump
inhibitors use and more severe atrophy and gastric intestinal metaplasia.
Eur J Gastroenterol Hepatol. 2025 Jun 4. doi: 10.1097/MEG.0000000000002989. PubMedAbstract available
April 2025
EL-AZAB G, Zakareya T, Abdel Aleem M, Edrees A, et al Inappropriate use of proton pump inhibitors in patients with liver cirrhosis: a
cross-sectional study.
Eur J Gastroenterol Hepatol. 2025 Apr 29. doi: 10.1097/MEG.0000000000002985. PubMedAbstract available
March 2025
WANG D, An TY, Hu QM, Hua YQ, et al Helicobacter pylori promotes YTHDF2-mediated SRA1 m6A modification and promotes
the occurrence and development of gastric cancer.
Eur J Gastroenterol Hepatol. 2025 Mar 21. doi: 10.1097/MEG.0000000000002972. PubMedAbstract available
February 2025
MAIMARIS S, Mangili L, Minerba P, Massetti G, et al Prevalence of gastroesophageal reflux disease in adult coeliac disease at
diagnosis and during follow-up: a 20-year retrospective study.
Eur J Gastroenterol Hepatol. 2025 Feb 21. doi: 10.1097/MEG.0000000000002953. PubMedAbstract available
January 2025
ZAIDI SMM, Alvi MH, Irfan Q, Abbasi L, et al The use of pre-endoscopic metoclopramide in patients with upper gastrointestinal
bleeding: a systematic review and meta-analysis.
Eur J Gastroenterol Hepatol. 2025 Jan 23. doi: 10.1097/MEG.0000000000002927. PubMedAbstract available
October 2024
KOZAI L, Tan A, Nebrejas K, Nishimura Y, et al Comparative diagnostic utility of Rockall and Glasgow-Blatchford scores in
non-variceal upper gastrointestinal bleeding: a systematic review and
meta-analysis.
Eur J Gastroenterol Hepatol. 2024 Oct 11. doi: 10.1097/MEG.0000000000002867. PubMedAbstract available
September 2024
ZHUO M, Fang M, Yin Y, Wang J, et al Investigating the prevalence burden of peptic ulcer disease in older adults aged
70+ from 1990 to 2019: an analysis of Global Disease Burden Studies.
Eur J Gastroenterol Hepatol. 2024 Sep 12. doi: 10.1097/MEG.0000000000002847. PubMedAbstract available
July 2024
LAM SK, Lau GKK Proton pump inhibitors are not associated with fundic gland polyps - a systematic
review that takes into consideration all known confounders.
Eur J Gastroenterol Hepatol. 2024;36:831-844. PubMedAbstract available
May 2024
SMITH SM, Boyle B, Buckley M, Costigan C, et al The second Irish Helicobacter pylori Working Group consensus for the diagnosis
and treatment of Helicobacter pylori infection in adult patients in Ireland.
Eur J Gastroenterol Hepatol. 2024 May 30. doi: 10.1097/MEG.0000000000002796. PubMedAbstract available
April 2024
LIU J, Zhang T, Liu X, Wang Q, et al Causal effect between gut microbiota and gastroesophageal reflux disease: a
bidirectional two-sample Mendelian randomization study.
Eur J Gastroenterol Hepatol. 2024 Apr 15. doi: 10.1097/MEG.0000000000002774. PubMedAbstract available
March 2024
QIAO Z, Wang E, Bao B, Tan X, et al Association of Helicobacter pylori CagA seropositivity with gastric precancerous
lesions: a systematic review and meta-analysis.
Eur J Gastroenterol Hepatol. 2024 Mar 19. doi: 10.1097/MEG.0000000000002765. PubMedAbstract available
LIU Z, Sun D, Kou L, Jia L, et al Vonoprazan-amoxicillin dual therapy with different amoxicillin dosages for
treatment-naive patients of Helicobacter pylori infection in China: a
prospective, randomized controlled study.
Eur J Gastroenterol Hepatol. 2024 Mar 19. doi: 10.1097/MEG.0000000000002760. PubMedAbstract available
SARIKAYA B, Cetinkaya RA, Ozyigitoglu D, Isik SA, et al High antibiotic resistance rates in Helicobacter pylori strains in Turkey over 20
years: implications for gastric disease treatment.
Eur J Gastroenterol Hepatol. 2024 Mar 11. doi: 10.1097/MEG.0000000000002733. PubMedAbstract available
September 2023
GINGOLD-BELFER R, Issa N, Boltin D, Beloosesky Y, et al Gastric cancer risk in the elderly is associated with omeprazole use and
inversely associated with aspirin use.
Eur J Gastroenterol Hepatol. 2023;35:968-973. PubMedAbstract available
August 2023
KROUPA R, Pavlik T, Konecny S, Packova B, et al The association between duration of and indications for proton pump inhibitor use
and risk of gastric polyps.
Eur J Gastroenterol Hepatol. 2023;35:829-835. PubMedAbstract available
June 2023
OKAMOTO T, Okamoto S, Yamamoto K, Takasu A, et al Bulbar and post-bulbar duodenal ulcers: characteristics based on location.
Eur J Gastroenterol Hepatol. 2023 Jun 22. doi: 10.1097/MEG.0000000000002585. PubMedAbstract available